Leaps by Bayer
Leaps by Bayer is the strategic investment unit of Bayer AG, backing teams pursuing paradigm-shifting innovations in the life sciences. We make significant, sustained investments in disruptive technologies in health and agriculture, targeting breakthroughs that could drive significant human and financial impact.
Leaps aims to address ten huge challenges in these fields.
Some call them impossible. We call them “leaps.”
Leaps by Bayer
Our last #LeapsTalk of 2019 at Summit LA, featured Peter Diamandis and explored how #CRISPR and #AI are shaping the next stage of human evolution.
Watch the full talk: bit.ly/2CZWbbK
5 years ago | [YT] | 0
View 0 replies
Leaps by Bayer
Our 3rd #LeapsTalk of 2019 at the Norrsken Foundation, featured Jamie Metzl and delved into how the exponential growth of #geneticengineering could bring about tremendous advances if guided by humanistic values.
Watch the full talk: bit.ly/2YxY3zQ
5 years ago (edited) | [YT] | 0
View 0 replies
Leaps by Bayer
This insightful throwback comes from our 2nd Leaps Talk at last year’s Boston HubWeek where co-founder of Ginkgo Bioworks, Reshma Shetty offered an important lesson to those eager to start their own #biotech company. Looking forward to more Leaps Talks in 2020.
Watch the full talk here: bit.ly/2Dm4Ip8
5 years ago | [YT] | 0
View 0 replies
Leaps by Bayer
Last year, together with the Norrsken Foundation, we introduced Leaps Talks at @techopenUG to foster important conversations about ethical innovation in life sciences. Erika Cheung (Theranos whistleblower) and Seth Bannon (tech turned biotech investor) look at how #biotech companies must balance the speed needed to drive innovative disruption with the rigor required to ensure patient safety at all cost.
Watch the full talk here: bit.ly/2Cyf85f
5 years ago | [YT] | 0
View 0 replies